公司概覽
業務類別 Biotechnology
業務概覽 Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
公司地址 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
電話號碼 +1 612 379-8854
傳真號碼 +1 612 656-4400
公司網頁 https://www.bio-techne.com
員工數量 3100
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. William Geist President, Protein Sciences 美元 573.20K 22/08/2025
Mr. Kim Kelderman Director, Chief Executive Officer and President 美元 936.00K 19/09/2025
Mr. Shane Bohnen Senior Vice President, General Counsel and Corporate Secretary 美元 431.00K 22/08/2025
Mr. Steve Crouse President, Diagnostics and Spatial Biology Segment -- 11/02/2026
Mr. James T. Hippel Principal Accounting Officer, Executive Vice President and Chief Financial Officer 美元 723.00K 22/08/2025
 
董事會成員
董事會 職務 更新日期
Mr. Kim Kelderman Director, Chief Executive Officer and President 19/09/2025
Dr. Alpna Seth, PhD Independent Director 19/09/2025
Dr. Rupert Vessey, B.M.,D.Phil.,F.R.C.P.,M.A. Independent Director 19/09/2025
Mr. John L. Higgins Independent Director 19/09/2025
Ms. Julie L. Bushman Independent Director 19/09/2025
Dr. Judith Klimovsky, M.D. Independent Director 19/09/2025
Mr. Robert V. Baumgartner, C.P.A. Chairman of the Board 19/09/2025
Dr. Joseph D. Keegan, PhD Independent Director 19/09/2025
Dr. Amy Herr, PhD Independent Director 19/09/2025
 
所屬ETF (更新日期: 02/05/2026 02:09)
代號 名稱 佔比% 持有日期
SMAPAmplify Small-Mid Cap Equity ETF0.0002%29/04/2026
GOFGuggenheim Strategic Opp Fund0.0002%30/11/2025
SHRTGotham Short Strategies ETF0.0002%28/04/2026
SPXNProShares S&P 500® ex-Financials0.0001%29/04/2026
SPXEProShares S&P 500® ex-Energy0.0001%29/04/2026
ACSVAmerican Century Small Cp Val Insgts ETF0.0001%29/04/2026
XOEFiShares S&P 500 ex S&P 100 ETF0.0001%29/04/2026
XYLGGlobal X S&P 500® Covered Call & Gr ETF0.0001%29/04/2026
WDNAWisdomTree BioRevolution ETF0.0001%28/04/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.0001%29/04/2026
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%29/04/2026
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%29/04/2026
SPYHNEOS S&P 500 Hedged Equity Income ETF0.0001%29/04/2026
TOPCiShares S&P 500 3% Capped ETF0.0001%29/04/2026
MNZLManzil Russell Halal USA Broad MarketETF0.0001%29/04/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%29/04/2026
INROiShares U.S. Industry Rotation Act ETF0.00005%17/04/2026
CDEICalvert US Large-Cp Div, Eq AndIncETF0.00003%29/04/2026
CHRIGlobal X S&P 500 Christian Values ETF0.00002%29/04/2026
SPXDXtrackers S&P 500 Divers Sect Weight ETF0.00002%29/04/2026
  1    2    3    4    5    6    7   8    9    10    11  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.